Everything below concerns GLP-1 analog. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Updated 2026-06-06. Numbers and descriptions here follow the published literature rather than marketing material.
Semaglutide is a synthetic peptide analog of human glucagon-like peptide-1, a gut hormone released after meals. Its backbone retains the GLP-1 sequence but incorporates two substitutions that slow enzymatic breakdown by dipeptidyl peptidase-4. A short polyethylene glycol linker and a C18 fatty diacid are attached to the peptide chain, allowing the molecule to bind serum albumin and remain in circulation far longer than the native hormone. The result is a circulating half-life measured in days rather than the minutes typical of endogenous GLP-1.
Receptor activation occurs at GLP-1 receptors distributed across pancreatic islets, the hypothalamus, and the gastrointestinal tract. Binding triggers G protein signaling that raises cyclic AMP and enhances glucose-dependent insulin release. Because the effect depends on prevailing glucose levels, insulin secretion does not rise when blood sugar is already low. Signaling in the brain and gut also influences appetite and gastric emptying, which is why the compound appears in both metabolic and weight-related research literature.
Semaglutide 是一种经结构修饰的胰高血糖素样肽-1 类似物，其主链与内源性 GLP-1(7-36) 约有百分之九十四的序列一致性。第 8 位丙氨酸被 α-氨基异丁酸取代，使二肽基肽酶-4 无法识别原有切割位点。第 34 位赖氨酸换为精氨酸，进一步降低酶解速率。第 26 位赖氨酸经间隔基连接一条含十八个碳的二酸脂肪链，该侧链赋予分子与血浆白蛋白结合的能力。
该分子作为 GLP-1 受体的选择性激动剂发挥作用，受体属于 B 类 G 蛋白偶联受体家族，激活后经 Gs 通路提升细胞内环腺苷酸水平。在胰腺 β 细胞，信号促进葡萄糖依赖性的胰岛素释放，血糖偏低时该作用明显减弱。在胰岛 α 细胞，胰高血糖素分泌受到抑制。中枢神经系统与胃肠道同样存在受体表达，相应信号参与食欲调节以及胃排空速率的降低。
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic peptide, GLP-1 receptor agonist | Not a small molecule |
| Backbone substitutions | Non-natural residue at position 8, arginine at position 34 | Slows enzymatic cleavage |
| Side chain | C18 fatty diacid with PEG linker | Enables albumin binding |
| Approximate molecular mass | 4114 Da | Varies slightly with salt form |
| Reported half-life | About one week | Longer than native GLP-1 by orders of magnitude |
Lyophilised semaglutide is generally held at -20 °C or below, protected from light and moisture. Reconstituted solutions are typically kept at 2-8 °C and used within a defined window because degradation accumulates over time. Repeated freeze-thaw cycles are discouraged, since each cycle can promote aggregation and reduce monomeric content. Room-temperature stability of the solid has been examined in some studies but remains incompletely characterised for long durations, so cold storage is the conservative default for research material.
Degradation proceeds along several parallel routes. Deamidation of asparagine and glutamine residues generates charged variants that shift retention time in chromatographic analysis. Oxidation targets methionine and can be accelerated by trace metals or dissolved oxygen. Non-covalent aggregation produces dimers, oligomers, and larger species that are difficult to reverse. Isomerisation at aspartate residues is slower but measurable under thermal stress. The distribution among these pathways depends on pH, buffer composition, ionic strength, and the presence of excipients such as sugars or surfactants.
Semaglutide is a synthetic peptide of thirty-one amino acids that shares roughly ninety-four percent sequence identity with human glucagon-like peptide-1. Two substitutions resist enzymatic cleavage by dipeptidyl peptidase-4, and a fatty diacid side chain attached through a linker promotes binding to serum albumin. That albumin binding slows renal clearance and extends the circulating half-life from minutes to approximately one week. The structural changes are well established in the published literature. Whether the same modifications affect receptor signalling bias in ways that matter clinically remains an open question.
Pharmacological activity arises from agonism at the glucagon-like peptide-1 receptor, a G protein-coupled receptor expressed in the pancreas, the gastrointestinal tract, and the brainstem. Receptor activation raises intracellular cyclic adenosine monophosphate and enhances insulin release in a glucose-dependent manner, an effect that diminishes when blood glucose concentration is low. Other effects include slowed gastric emptying and hypothalamic satiety signalling. These pathways are described well. Receptor desensitisation rates across tissues, relative to the endogenous hormone, are still under investigation, and reported findings differ between laboratories.
== Further reading == Manna, Utpal; Sritharan, S. S. (2007). "Lyapunov Functionals and Local Dissipativity for the Vorticity Equation in Lp and Besov spaces". Differential and Integral Equations. 20 (5): 581–598. arXiv:0802.2898. doi:10.57262/die/1356039440. S2CID 50701138. Barbu, V.; Sritharan, S. S. (2000). "M-Accretive Quantization of the Vorticity Equation" (PDF). In Balakrishnan, A. V. (ed.). Semi-Groups of Operators: Theory and Applications. Boston: Birkhauser. pp. 296–303. Krigel, A. M. (1983). "Vortex evolution". Geophysical & Astrophysical Fluid Dynamics. 24 (3): 213–223. Bibcode:1983GApFD..24..213K. doi:10.1080/03091928308209066.
The heightened vigilance of the German garrison as the war entered its final phase made these operations especially hazardous, particularly as they were often attempted at extremely close quarters. On several occasions Rhodesian patrols only narrowly escaped discovery. During one action, two Rhodesian patrols catered for the possibility that Germans might be listening to their transmissions by communicating in Shona, an African language. The LRDG's last actions of the war, in April and May 1945, were to help Tito's partisans capture German-held islands off Dalmatia.
== Treatment == The management of lipodermatosclerosis may include treating venous insufficiency with leg elevation and elastic compression stockings. In some difficult cases, the condition may be improved with the additional use of the fibrinolytic agent, stanozol. Fibrinolytic agents use an enzymatic action to help dissolve blood clots. Stanozol is injected directly into the affected area. Venous Ablation has also been known to help circulation in patients. Lifestyle changes such as maintaining a healthy weight & diet, exercising regularly, avoiding prolonged sitting or standing, and elevating your legs can play a significant role in managing lipodermatosclerosis and reducing its symptoms.
Sources: en.wikipedia.org
Another major cause of chronic wounds, diabetes, is increasing in prevalence. Diabetics have a 15% higher risk for amputation than the general population due to chronic ulcers. Diabetes causes neuropathy, which inhibits nociception and the perception of pain. Thus patients may not initially notice small wounds to legs and feet, and may therefore fail to prevent infection or repeated injury. Further, diabetes causes immune compromise and damage to small blood vessels, preventing adequate oxygenation of tissue, which can cause chronic wounds. Pressure also plays a role in the formation of diabetic ulcers.
Spinneys, which holds a 50-year lease with a 382,900 ft² cold storage distribution centre BRF (Brasil Foods), which operates a 1.6 million sq plant producing meat products and bread-based foods under the Sadia brand. Emirates Calcium Carbonate Factory, established under a 50-year agreement to supply products for oilfield industries Palletco, a manufacturing facility under a 50-year lease agreement. Apex Engineering Industries, an AED 90 million manufacturing facility for oil, gas and defence. Abundance Solar Panel Industries, an AED 55 million solar production plant. Global logistics companies, including DHL Global Forwarding and DSV, which provide logistics and supply chain services. Azizi Developments, which signed a 50-year land lease agreement to build 12 factories with an investment of AED 1 billion. Jiangsu Overseas Cooperation Investment Co. Ltd (JOCIC), established in 2017 to manage the China-UAE Industrial Capacity Cooperation Demonstration Zone. Built-to-suit
=== Topical applications === Topical preparations of immunosuppressing medications, including glucocorticoids (such as 0.05% clobetasol or 0.10% betamethasone) and calcineurin inhibitors (such as tacrolimus or pimecrolimus) are considered to be first-line treatments for vitiligo. In July 2022, ruxolitinib cream (a Janus-kinas inhibitor sold under the brand name Opzelura) was approved for medical use in the United States for the treatment of vitiligo. According to one study, there is moderate evidence that topical steroids have a positive effect.
Sources: en.wikipedia.org
Native GLP-1 is degraded within minutes by circulating enzymes. The synthetic version carries substitutions at positions that block enzymatic cleavage, plus a fatty acid side chain that promotes albumin binding. These two changes together extend circulation time from minutes to roughly a week.
Albumin binding keeps a large fraction of the compound in a slowly released reservoir within the bloodstream. Plasma levels decline gradually rather than falling sharply after each administration. That profile supports dosing intervals measured in days instead of hours.
The active peptide sequence is the same in both formats. The oral version adds an absorption enhancer that is not present in the injected solution. Differences in excipients and formulation affect uptake rather than the identity of the active molecule.
差别集中在三处：第 8 位残基被非天然氨基酸取代，第 34 位换成精氨酸，第 26 位增加一条脂肪酸侧链。前两处改动降低酶解速率，侧链则通过白蛋白结合延长循环时间。综合结果是半衰期从约两分钟延长到约一周。